Depomed, Inc. (DEPO)
(Real Time Quote from BATS)
$7.30 USD
+0.12 (1.67%)
Updated Aug 14, 2018 04:00 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Assertio Holdings, Inc. [DEPO]
Reports for Purchase
Showing records 1 - 20 ( 602 total )
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
Updated Model - Valuation Compelling with Potential Cosyntropin Upside
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
2Q17 Recap - Macro Challenges Worsen, But Signs of Hope (Eventually)
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
Updated Model, PT reduced to $16/ share - Maintain Buy
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
Updated Model - Potential Winner When Opioid Market Stabilizes
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
Nucynta Tracker - Week ending 2/10/2017 (Lowering #''s Again)
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S